Search Results

There are 136290 results for: content related to: Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer

  1. You have full text access to this OnlineOpen article
    A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer


    Volume 110, Issue 9, 1 November 2007, Pages: 1959–1966, Michael A. Carducci, Fred Saad, Per-Anders Abrahamsson, David P. Dearnaley, Claude C. Schulman, Scott A. North, Darryl J. Sleep, Jeffrey D. Isaacson, Joel B. Nelson and for the Atrasentan Phase III Study Group Institutions.

    Article first published online : 20 SEP 2007, DOI: 10.1002/cncr.22996

  2. You have full text access to this OnlineOpen article
    Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer


    Volume 107, Issue 3, 1 August 2006, Pages: 530–535, M. Dror Michaelson, Donald S. Kaufman, Philip Kantoff, William K. Oh and Matthew R. Smith

    Article first published online : 27 JUN 2006, DOI: 10.1002/cncr.22043

  3. You have free access to this content
    Role of the endothelin axis and its antagonists in the treatment of cancer

    British Journal of Pharmacology

    Volume 163, Issue 2, May 2011, Pages: 220–233, A Bagnato, M Loizidou, BR Pflug, J Curwen and J Growcott

    Article first published online : 18 APR 2011, DOI: 10.1111/j.1476-5381.2011.01217.x

  4. Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan

    The Journal of Clinical Pharmacology

    Volume 47, Issue 4, April 2007, Pages: 423–429, Dr Hao Xiong, Dr Robert A. Carr, Dr Charles S. Locke, Dr David A. Katz, Dr Ramanuj Achari, Dr Thao T. Doan, Dr Perry Wang, Mr James R. Jankowski and Dr Darryl J. Sleep

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270007299928

  5. You have full text access to this OnlineOpen article
    Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone


    Volume 118, Issue 22, 15 November 2012, Pages: 5709–5718, Joel B. Nelson, Karim Fizazi, Kurt Miller, Celestia Higano, Judd W. Moul, Hideyuki Akaza, Thomas Morris, Stuart McIntosh, Kristine Pemberton and Martin Gleave

    Article first published online : 11 JUL 2012, DOI: 10.1002/cncr.27674

  6. You have full text access to this OnlineOpen article
    Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

    International Journal of Cancer

    Volume 127, Issue 3, 1 August 2010, Pages: 696–706, Jeanett Fischgräbe, Martin Götte, Katharina Michels, Ludwig Kiesel and Pia Wülfing

    Article first published online : 3 DEC 2009, DOI: 10.1002/ijc.25076

  7. You have full text access to this OnlineOpen article
    Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase

    British Journal of Pharmacology

    Volume 148, Issue 5, July 2006, Pages: 671–681, Gerald Wölkart, Heike Stessel, Zora Saad, Michael Kirchengast and Friedrich Brunner

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706772

  8. Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus Non-US sites? analysis from the ACUITY trial

    Catheterization and Cardiovascular Interventions

    Volume 82, Issue 4, 1 October 2013, Pages: E365–E374, Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David A. Cox, Martin Fahy, Ke Xu, Roxana Mehran and Gregg W. Stone

    Article first published online : 9 MAR 2013, DOI: 10.1002/ccd.24587

  9. Authors' Response

    The Journal of Clinical Pharmacology

    Volume 47, Issue 9, September 2007, Page: 1182, Hao Xiong and Robert A. Carr

    Article first published online : 23 APR 2013, DOI: 10.1177/0091270007305472

  10. You have free access to this content
    Constructing an Identity between Arabism and Islam: The Druzes in Syria

    The Muslim World

    Volume 103, Issue 1, January 2013, Pages: 62–79, Birgit Schaebler

    Article first published online : 4 MAR 2013, DOI: 10.1111/muwo.12002

  11. You have full text access to this OnlineOpen article
    Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: Evidence from an individual patient analysis


    Volume 118, Issue 9, 1 May 2012, Pages: 2525–2531, George R. Simon, Michael J. Schell, Mubeena Begum, Jongphil Kim, Alberto Chiappori, Eric Haura, Scott Antonia and Gerold Bepler

    Article first published online : 25 OCT 2011, DOI: 10.1002/cncr.26522

  12. You have full text access to this OnlineOpen article
    Targeted therapy in prostate cancer—Are we our own worst enemy?


    Volume 113, Issue 9, 1 November 2008, Pages: 2376–2378, Nancy A. Dawson

    Article first published online : 8 SEP 2008, DOI: 10.1002/cncr.23865

  13. Activation of the ET-1/ETA Pathway Contributes to Erectile Dysfunction Associated with Mineralocorticoid Hypertension

    The Journal of Sexual Medicine

    Volume 5, Issue 12, December 2008, Pages: 2793–2807, Fernando S. Carneiro, Kênia P. Nunes, Fernanda R.C. Giachini, Victor V. Lima, Zidonia N. Carneiro, Edson F. Nogueira, Romulo Leite, Adviye Ergul, William E. Rainey, R. Clinton Webb and Rita C. Tostes

    Article first published online : 24 SEP 2008, DOI: 10.1111/j.1743-6109.2008.01009.x

  14. Temperature-mediated plasticity and genetic differentiation in egg size and hatching size among populations of Crepidula (Gastropoda: Calyptraeidae)

    Biological Journal of the Linnean Society

    Volume 99, Issue 3, March 2010, Pages: 489–499, RACHEL COLLIN and MARICELA Z. SALAZAR

    Article first published online : 5 FEB 2010, DOI: 10.1111/j.1095-8312.2009.01388.x

  15. Prostate Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt015


    BJU International

    Volume 107, Issue 5, March 2011, Pages: 697–700, Roger S. Kirby and John M. Fitzpatrick

    Article first published online : 11 FEB 2011, DOI: 10.1111/j.1464-410X.2010.10027.x

  17. You have full text access to this OnlineOpen article
    Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats

    British Journal of Pharmacology

    Volume 151, Issue 8, August 2007, Pages: 1187–1197, G Wölkart, X Pang, H Stessel, M Kirchengast and F Brunner

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707325

  18. Role of the endothelin axis in the proliferation of human thyroid cancer cells

    Clinical Endocrinology

    Volume 67, Issue 4, October 2007, Pages: 552–556, Julian E. Donckier, Jeannine Mertens-Strijthagen and Bruno Flamion

    Article first published online : 24 MAY 2007, DOI: 10.1111/j.1365-2265.2007.02923.x

  19. Facing the Sunrise: Cultural Worldview Underlying Intrinsic-Based Encoding of Absolute Frames of Reference in Aymara

    Cognitive Science

    Volume 36, Issue 6, August 2012, Pages: 965–991, Rafael E. Núñez and Carlos Cornejo

    Article first published online : 14 MAR 2012, DOI: 10.1111/j.1551-6709.2012.01237.x

  20. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Article first published online : 24 APR 2012, DOI: 10.3322/caac.21141